Fundraising Fox
🦊/People
Sign in

Ted Lamson

Founder

Founder at NeoTract

Alamo, California, United States

FoundedNeoTract

Find your path to Ted

281 people in our graph share verified history with Ted — schools, employers, funds. One of them is your warm intro.

Lawrence BettinounlockedTed: together at Rensselaer Polytechnic Institute (1979–1982)
×3Ted: together at Penn State University
×5Ted: together at Rensselaer Polytechnic Institute
Ted: together at Calyxo

About

Ted Lamson is a medical device developer with over 25 years of experience across interventional cardiology, catheter-based therapies, stem cell technology, ENT, and urology, beginning with the Penn State artificial heart. He co-founded NeoTract and co-invented the UroLift treatment within the ExploraMed incubator, and now serves as a Strategic Advisor at ProVerum. He consults for Teleflex, which acquired NeoTract, and participates in start-up activities including board positions.

Founder at NeoTract

Intro paths

→

In turn, Ted can intro founders to NeoTract's investors below.

NeoTract's investors · 2

New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2016Windham Capital PartnersNew York · $1M – $5M checks · since 2016

Experience

  1. ProVerumStrategic Advisorcurrent2025 — present
  2. Eximis SurgicalBoard Membercurrent2019 — present
  3. Calyxo, Inc.Strategic Advisorcurrent2019 — present
  4. MoximedCommercial Council Membercurrent2024 — present
  5. EXPLORAMED DEVELOPMENT LLCStrategic Advisorcurrent2006 — present
  6. Teleflex IncorporatedConsultant2019 — 2025
  7. Palette Life SciencesBoard Member2021 — 2023
  8. NeoTract, Inc.Founder & Chief Technical Officer2009 — 2019
  9. NeoTract, Inc.President, CEO2005 — 2009
  10. Medtronic VascularVP Advanced Technologies2003 — 2004
  11. TransVascularVP R&D1997 — 2003
  12. NAMIC Corp.R&D Section Manager1993 — 1997

Skills & more

Urology15Product Launch16Clinical Trials26R&D22ISO 134858Medical Devices40Biotechnology6Quality System4Start-ups6Commercialization8Design Control12Clinical Development7
+12 moreDesign for ManufacturingFDABiomedical EngineeringRegulatory AffairsProduct DevelopmentProduct ManagementHealthcareEnterprise SoftwarePatentsMarket DevelopmentClinical ResearchResearch and Development (R&D)

From Ted's professional profile.

Frequently asked questions

Who is Ted Lamson?
Ted Lamson is a medical device developer with over 25 years of experience across interventional cardiology, catheter-based therapies, stem cell technology, ENT, and urology, beginning with the Penn State artificial heart. He co-founded NeoTract and co-invented the UroLift treatment within the ExploraMed incubator, and now serves as a Strategic Advisor at ProVerum. He consults for Teleflex, which acquired NeoTract, and participates in start-up activities including board positions.
Where does Ted Lamson work?
Ted Lamson is Founder of NeoTract.
What companies did Ted Lamson found?
Ted Lamson founded NeoTract.
Where did Ted Lamson go to school?
Ted Lamson studied at Penn State University (PhD, Bioengineering); Penn State University (MS, Bioengineering); Rensselaer Polytechnic Institute (BS, Chemical Engineering).

Founder mafias

Same school

Shared employers